Longboard Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatme…

Biotechnology
US, La Jolla [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Longboard Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Longboard Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Longboard Pharmaceuticals, Inc..

End of LBPH's Analysis
CIK: 1832168 CUSIP: 54300N103 ISIN: US54300N1037 LEI: - UEI: -
Secondary Listings
LBPH has no secondary listings inside our databases.